# Transcranial Photobiomodulation for Reducing Autism Symptoms in Children - Open Label Study (TPBMASDOL)

> **NCT06359080** · NA · COMPLETED · sponsor: **JelikaLite LLC** · enrollment: 25 (actual)

## Conditions studied

- Autism Spectrum Disorder

## Interventions

- **DEVICE:** Cognilum TM: Light Treatment Condition

## Key facts

- **NCT ID:** NCT06359080
- **Lead sponsor:** JelikaLite LLC
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-05-08
- **Primary completion:** 2022-12-11
- **Final completion:** 2022-12-11
- **Target enrollment:** 25 (ACTUAL)
- **Last updated:** 2024-06-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06359080

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06359080, "Transcranial Photobiomodulation for Reducing Autism Symptoms in Children - Open Label Study (TPBMASDOL)". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT06359080. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*